3652 results for «345»
3652 results
EuroPCR 2021 Hotlines / Late-Breaking Trials: TRILUMINATE, CLASP TR, bRIGHT, TRISCEND, TriBAND, and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in TRICUSPID:
- Percutaneous E2E repair for TR: 2-Year outcomes from the TRILUMINATE trial
- Transcatheter tricuspid valve repair: CLASP TR feasibility study 6-month results
- Clinical Response to Transcatheter treatment of tricuspid regurgitation: International TriValve registry
- Baseline characteristics and procedure outcomes from TriClip bRIGHT...
A review of the RADIANCE-HTN global clinical trial programme: a focus on the TRIO cohort
18 May 2021 – From EuroPCR 2021
Watch this session presented by Ajay Kirtane, Melvin David Lobo and Felix Mahfoud in order to review a history of the field and the recent clinical advancements in renal denervation with the Paradise Ultrasound RDN system, to further examine the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered...
TAVI in bicuspid aortic valve patients. SAPIEN 3 platform, a safe and efficient option
19 May 2021 – From EuroPCR 2021
Watch this session presented by Philippe Genereux, Didier Tchetche, Joerg Kempfer, Radoslaw Parma and Christoph Klein in order to understand which patients with bicuspid aortic valve are suitable for TAVI vs. SAVR, to learn about Edwards SAPIEN 3 being utilisation in patients with bicuspid aortic valve, and to know more about the...
EAPCI-PCR Fellows Course: interventions for calcified coronary lesions
18 May 2021 – From EuroPCR 2021
Watch this session if you want to review the role of imaging for procedural planning and to discuss the best indications for specific plaque modification techniques.
This session was originally presented during EuroPCR 2021.
Meta-analysis of elective coronary revascularization vs medical therapy alone
18 May 2021 – From EuroPCR 2021
This session, originally broadcast during EuroPCR 2021, presents a meta-analysis based on 25 trials dealing with revascularization in patients with chronic coronary syndromes and enables our experts to discuss the strengths and weaknesses of this study.
Introducing Navitor: a new TAVI solution
18 May 2021 – From EuroPCR 2021
Watch this session presented by Helge Möllmann, Lars Sondergaard, Maurizio Taramasso, Ganesh Manoharan and Dave Smith in order to discuss how to minimise resources needed for your TAVI procedure without compromising safety and efficacy, to demonstrate how to simplify your TAVI procedure, and to examine considerations for lifetime management of your...
One-year results from the FUTURE-II trial
19 May 2021 – From EuroPCR 2021
This LBT session, which was originally presented during EuroPCR 2021, deals with the FUTURE-II study on the new generation of bioresorbable scaffolds, providing comparative safety and efficacy evidence of the thinner-strut PLLA-based BRS in the treatment of patients with noncomplex coronary lesions.
Complete 2-year follow-up from the Evolut low risk trial
18 May 2021 – From EuroPCR 2021
This session was originally presented during EuroPCR 2021.
PCR London Valves 2021 – Welcome message
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
Real-world outcomes with the PASCAL Platform in TR
03 Dec 2021
The PASCAL platform, comprising the PASCAL and PASCAL Ace implants, received its CE mark for TR in May 2020 and has been shown to be an effective and safe treatment option for patients with TR.3,4,6 Professor Jörg Hausleiter and Dr Mirjam Wild now describe their single-centre experience...
One-year results of the Clasp TR Study: Transcatheter treatment of tricuspid regurgitation
22 Mar 2022
Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.
Author
Author
